BOCOM International: Raises Hansoh Pharmaceutical (03692.HK) target price to HK$46, maintains "Buy" rating.

Zhito Finance APP has learned that BOCOM International issued a research report stating that it has raised the target price of Hansoh Pharmaceutical (03692.HK) to HK$46, maintaining a "Buy" rating and keeping it as a top pick in the prescription drug industry. The bank also raised its revenue and profit forecasts for the company for 2026-2028, mainly based on strong revenue and margin performance in the first half of 2026, as well as the expected arrival of a new wave of innovative drug launches starting in 2027.